Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
24,187.60
(
2.75%
)
Dow Jones
46,584.46
(
-0.18%
)
Brent Oil
101.21
(
-5.47%
)
Bitcoin
72,214.13
(
4.87%
)
News Focus
News Focus
Post# of 3757
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122853
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 917

Monday, 04/23/2007 8:42:12 AM

Monday, April 23, 2007 8:42:12 AM

Post# of 3757
>…might Roche first try a lot lower dose of 1626 before trying another Polymerase?<

Sure—they may end up doing exactly that. The change is that R1626 has up to now been viewed as a shoo-in for combination with 191; now, it’s merely one of the options Roche may pursue.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote